Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2080-2086

  Jiang, Wei ^a,b   Lederman, Michael M ^a,b   Harding, Clifford V ^b   Sieg, Scott F ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; CYTOMEGALOVIRUS ANTIGEN PP65; DEXTRAN; GRANZYME B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TETANUS TOXOID; TOLL LIKE RECEPTOR 9 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD86; B-LYMPHOCYTE SUBSETS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; CROSS-PRIMING; ENDOCYTOSIS; G0 PHASE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; SOLUBILITY; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 79951840612     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001869     Document Type: Article

References (36)

1. Mouriès, J., G. Moron, G. Schlecht, N. Escriou, G. Dadaglio, and C. Leclerc. 2008. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 112: 3713-3722.
2. Pozzi, L. A., J. W. Maciaszek, and K. L. Rock. 2005. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J. Immunol. 175: 2071-2081.
3. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175: 131-138.
4. Rodríguez-Pinto, D., and J. Moreno. 2005. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur. J. Immunol. 35: 1097-1105.
5. Raimondi, G., I. Zanoni, S. Citterio, P. Ricciardi-Castagnoli, and F. Granucci. 2006. Induction of peripheral T cell tolerance by antigen-presenting B cells. II. Chronic antigen presentation overrules antigen-presenting B cell activation. J. Immunol. 176: 4021-4028.
6. Heit, A., K. M. Huster, F. Schmitz, M. Schiemann, D. H. Busch, and H. Wagner. 2004. CpG-DNA aided cross-priming by cross-presenting B cells. J. Immunol. 172: 1501-1507. (Pubitemid 38116793)
7. Castiglioni, P., M. Gerloni, and M. Zanetti. 2004. Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells. Vaccine 23: 699-708. (Pubitemid 39473202)
8. Filaci, G., M. Gerloni, M. Rizzi, P. Castiglioni, H. D. Chang, M. C. Wheeler, R. Fiocca, and M. Zanetti. 2004. Spontaneous transgenesis of human B lymphocytes. Gene Ther. 11: 42-51. (Pubitemid 38111387)
9. Attanavanich, K., and J. F. Kearney. 2004. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172: 803-811.
10. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258: 1156-1159.
11. Reichardt, P., B. Dornbach, S. Rong, S. Beissert, F. Gueler, K. Loser, and M. Gunzer. 2007. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 110: 1519-1529. (Pubitemid 47443968)
12. Wu, H. Y., A. Monsonego, and H. L. Weiner. 2006. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression. J. Autoimmun. 26: 116-126.
13. Buhlmann, J. E., T. M. Foy, A. Aruffo, K. M. Crassi, J. A. Ledbetter, W. R. Green, J. C. Xu, L. D. Shultz, D. Roopesian, R. A. Flavell, et al. 1995. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2: 645-653.
14. Clatza, A., L. C. Bonifaz, D. A. Vignali, and J. Moreno. 2003. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation. J. Immunol. 171: 6478-6487. (Pubitemid 37532076)
15. Evans, D. E., M. W. Munks, J. M. Purkerson, and D. C. Parker. 2000. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J. Immunol. 164: 688-697.
16. Ivanov, R., T. Aarts, A. Hagenbeek, S. Hol, and S. Ebeling. 2005. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC. Cytotherapy 7: 62-73. (Pubitemid 40542405)
17. Tobian, A. A., C. V. Harding, and D. H. Canaday. 2005. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes. J. Immunol. 174: 5209-5214.
18. Yuschenkoff, V. N., M. P. Sethna, G. J. Freeman, and D. C. Parker. 1996. Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. J. Immunol. 157: 1987-1995.
19. Krug, A., A. Towarowski, S. Britsch, S. Rothenfusser, V. Hornung, R. Bals, T. Giese, H. Engelmann, S. Endres, A. M. Krieg, and G. Hartmann. 2001. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31: 3026-3037.
20. Krug, A., S. Rothenfusser, V. Hornung, B. Jahrsdörfer, S. Blackwell, Z. K. Ballas, S. Endres, A. M. Krieg, and G. Hartmann. 2001. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31: 2154-2163.
21. Bourke, E., D. Bosisio, J. Golay, N. Polentarutti, and A. Mantovani. 2003. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102: 956-963. (Pubitemid 36917790)
22. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537. (Pubitemid 34441357)
23. Cao, W., S. Manicassamy, H. Tang, S. P. Kasturi, A. Pirani, N. Murthy, and B. Pulendran. 2008. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat. Immunol. 9: 1157-1164.
24. Gray, R. C., J. Kuchtey, and C. V. Harding. 2007. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs. J. Leukoc. Biol. 81: 1075-1085.
25. Guiducci, C., G. Ott, J. H. Chan, E. Damon, C. Calacsan, T. Matray, K. D. Lee, R. L. Coffman, and F. J. Barrat. 2006. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203: 1999-2008.
26. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202. (Pubitemid 35471246)
27. Jiang, W., M. M. Lederman, C. V. Harding, B. Rodriguez, R. J. Mohner, and S. F. Sieg. 2007. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. Eur. J. Immunol. 37: 2205-2213.
28. Kam, C. M., D. Hudig, and J. C. Powers. 2000. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. Biochim. Biophys. Acta 1477: 307-323.
29. Heit, A., T. Maurer, H. Hochrein, S. Bauer, K. M. Huster, D. H. Busch, and H. Wagner. 2003. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells. J. Immunol. 170: 2802-2805. (Pubitemid 36302148)
30. Qi, H., J. G. Egen, A. Y. Huang, and R. N. Germain. 2006. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312: 1672-1676.
31. Takahashi, K., A. Kenji, T. Norihiro, K. Eisaku, O. Takashi, H. Kazuhiko, Y. Tadashi, and A. Tadaatsu. 2001. Morphological interactions of interdigitating dendritic cells with B and T cells in human mesenteric lymph nodes. Am. J. Pathol. 159: 131-138.
32. Tobian, A. A., N. S. Potter, L. Ramachandra, R. K. Pai, M. Convery, W. H. Boom, and C. V. Harding. 2003. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J. Immunol. 171: 1413-1422. (Pubitemid 36900075)
33. Hartmann, G., R. D. Weeratna, Z. K. Ballas, P. Payette, S. Blackwell, I. Suparto, W. L. Rasmussen, M. Waldschmidt, D. Sajuthi, R. H. Purcell, et al. 2000. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164: 1617-1624.
34. Cooper, C. L., H. L. Davis, J. B. Angel, M. L. Morris, S. M. Elfer, I. Seguin, A. M. Krieg, and D. W. Cameron. 2005. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. AIDS 19: 1473-1479.
35. Cooper, C. L., H. L. Davis, M. L. Morris, S. M. Efler, M. A. Adhami, A. M. Krieg, D. W. Cameron, and J. Heathcote. 2004. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J. Clin. Immunol. 24: 693-701.
36. Hoft, D. F., C. S. Eickhoff, O. K. Giddings, J. R. Vasconcelos, and M. M. Rodrigues. 2007. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J. Immunol. 179: 6889-6900.